<- Go Home
Amyris, Inc.
Amyris, Inc. manufactures and sells hydrocarbon molecule and bio-based product. The company’s products include fermented fragrance material, plant-based silicon, sandalwood oil, manool, fermented bisabolo for anti-infection, artemisinic acid, silica for cosmetics, and cannabinoid. The company uses synthetic biology process to manufacture ingredient. The company caters to cosmetic, personal care, and pharmaceutical industry. Amyris, Inc. was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. The company was founded in 2003 and is based in EmeryVille, California.
Market Cap
$744.6K
Volume
6.2M
Cash and Equivalents
$11.2M
EBITDA
-$566.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$101.6M
Profit Margin
37.86%
52 Week High
$1.32
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
-0.00
Price / Earnings
-0.00
Price / Tangible Book Value
-0.00
Enterprise Value
$1.0B
Enterprise Value / EBITDA
-1.89
Operating Income
-$585.7M
Return on Equity
163.02%
Return on Assets
-46.39
Cash and Short Term Investments
$11.2M
Debt
$1.0B
Equity
-$648.1M
Revenue
$268.2M
Unlevered FCF
-$302.9M
Sector
Chemicals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium